Welcome to the new Regeneron Newsroom. This newsroom is designed to provide members of the media with easy access to up-to-date information about the Company.

For an e-mail response to questions about Regeneron, please contact us at

Upcoming Events

Feb 9, 2016
8:30 AM ET
Webcast Regeneron Pharmaceuticals Q4 2015 Earnings Conference Call
Feb 11, 2016
8:30 AM
Webcast Leerink Partners 5th Annual Global Healthcare Conference

View all releases Recent Press Releases

Feb 2, 2016 Regeneron Announces Upcoming 2016 Investor Conference Presentation
Feb 2, 2016 Regeneron and Sanofi Announce Publication of Positive Phase 2 Dupilumab Data in the Journal of the American Medical Association
Jan 26, 2016 Regeneron to Report Fourth Quarter and Full Year 2015 Financial and Operating Results and Host Conference Call and Webcast on February 9, 2016
Jan 8, 2016 Regeneron and Sanofi Announce Sarilumab Biologics License Application Accepted for Review by US FDA
Jan 7, 2016 Regeneron Announces Presentation at the 34th Annual J.P. Morgan Healthcare Conference
Dec 27, 2015 Regeneron Mourns Passing of Dr. Alfred G. Gilman, Board Member and Nobel Laureate
Dec 11, 2015 Regeneron and Sanofi Announce UnitedHealth Group Selects Praluent® (alirocumab) Injection for Preferred Access
Nov 24, 2015 Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled
Nov 12, 2015 Regeneron Celebrates Patient Innovation and Growth in New York State
Nov 10, 2015 Regeneron and Sanofi Announce New Praluent® (alirocumab) Injection Analyses Presented at AHA Scientific Sessions 2015

Form content here please :)